Litigation
In re Sitagliptin Phosphate ('708 & '921) Patent Litigation
consolidated MDL; claim construction issued1:19-md-02902-RGA
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Filed
- 2019-08-08
Patents at issue (2)
Summary
MDL No. 2902 centralizing 14 actions (13 in D. Del. and 1 in N.D. W. Va.) for coordinated litigation involving U.S. Patent Nos. 7,326,708 and 8,414,921. The court issued claim construction on Nov. 17, 2020.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).